Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months of Fiscal Year 2023 and Full Year May 31, 2023
For the full year, the company expects net sales to be JPY 51,909 million, operating profit to be JPY 1,606 million, earnings attributable to owners of parent to be JPY 543 million or JPY 58.07 per share.